BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25238893)

  • 21. Definition and symptoms of underactive bladder.
    Uren AD; Drake MJ
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S61-S67. PubMed ID: 29279877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of underactive bladder.
    Chang YH; Siu JJ; Hsiao PJ; Chang CH; Chou EC
    J Formos Med Assoc; 2018 Mar; 117(3):178-184. PubMed ID: 28969876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.
    Izumi K; Maolake A; Maeda Y; Shigehara K; Namiki M
    Minerva Urol Nefrol; 2014 Dec; 66(4):241-7. PubMed ID: 25531193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is coexistent overactive-underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI-RS 2019.
    Mancini V; Tarcan T; Serati M; Wyndaele M; Carrieri G; Abrams P
    Neurourol Urodyn; 2020 Jul; 39 Suppl 3():S50-S59. PubMed ID: 32032454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapeutic directions to treat underactive bladder.
    Chai TC; Kudze T
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S99-S106. PubMed ID: 29279882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The underactive bladder: a new clinical concept?
    Chapple CR; Osman NI; Birder L; van Koeveringe GA; Oelke M; Nitti VW; Drake MJ; Yamaguchi O; Abrams P; Smith PP
    Eur Urol; 2015 Sep; 68(3):351-3. PubMed ID: 25770481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of underactive bladder.
    Ko KJ; Lee CU; Lee KS
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S75-S81. PubMed ID: 29279879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current pharmacological and surgical treatment of underactive bladder.
    Kim DK
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S90-S98. PubMed ID: 29279881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of the underactive bladder.
    Aizawa N; Igawa Y
    Investig Clin Urol; 2017 Dec; 58(Suppl 2):S82-S89. PubMed ID: 29279880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel animal model of underactive bladder: analysis of lower urinary tract function in a rat lumbar canal stenosis model.
    Sekido N; Jyoraku A; Okada H; Wakamatsu D; Matsuya H; Nishiyama H
    Neurourol Urodyn; 2012 Sep; 31(7):1190-6. PubMed ID: 22473471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB).
    Dewulf K; Abraham N; Lamb LE; Griebling TL; Yoshimura N; Tyagi P; Veerecke A; Bartolone SN; Zwaans BMM; De Ridder D; Diokno A; Chancellor MB
    Int Urol Nephrol; 2017 May; 49(5):777-785. PubMed ID: 28233085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the urinary bladder dysfunction in renovascular hypertensive rats.
    Ramos-Filho AC; Mónica FZ; Franco-Penteado CF; Rojas-Moscoso JA; Báu FR; Schenka AA; De Nucci G; Antunes E
    Neurourol Urodyn; 2011 Sep; 30(7):1392-402. PubMed ID: 21661033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of urethral flow-evoked voiding reflexes decline with age in the rat: insights into age-related underactive bladder.
    Geramipour A; Danziger ZC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1430-F1440. PubMed ID: 32363884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The overactive bladder progression to underactive bladder hypothesis.
    Chancellor MB
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S23-7. PubMed ID: 25238891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detrusor underactivity/underactive bladder: new research initiatives needed.
    Andersson KE
    J Urol; 2010 Nov; 184(5):1829-30. PubMed ID: 20846686
    [No Abstract]   [Full Text] [Related]  

  • 36. Bladder instability: a re-appraisal of classical experimental approaches and development of new therapeutic strategies.
    Boselli C; Govoni S; Condino AM; D'Agostino G
    J Auton Pharmacol; 2001; 21(5-6):219-29. PubMed ID: 12123466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder.
    Mizutani H; Sakakibara F; Sasaki E
    J Pharmacol Exp Ther; 2020 Jul; 374(1):84-92. PubMed ID: 32332112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of voiding function and structural bladder changes in a rat model of neurogenic underactive bladder disease.
    Weyne E; Dewulf K; Deruyer Y; Rietjens R; Everaerts W; Bivalacqua TJ; De Ridder D; Van der Aa F; Albersen M
    Neurourol Urodyn; 2018 Jun; 37(5):1594-1604. PubMed ID: 30105760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.
    Semins MJ; Chancellor MB
    Nat Clin Pract Urol; 2004 Dec; 1(2):78-84; quiz 109. PubMed ID: 16474519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.